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Background: The cavitating mesenteric lymph node syndrome (CMLNS) is a rare manifestation of celiac disease,
with an estimated mortality rate of 50%. Specific infections and malignant lymphoma may complicate its clinical
course and contribute to its poor prognosis. Diagnosing the underlying cause of CMLNS can be challenging. This is
the first report on contrast enhanced ultrasound (CEUS) findings in enteropathy associated T-cell lymphoma (EATL)
complicating CMLNS in a gluten-free compliant patient with persistent symptoms and poor outcome.
Case presentation: We present the case of a 51-year old Caucasian male patient, diagnosed with celiac disease
and CMLNS. Despite his compliance to the gluten-free diet the symptoms persisted and we eventually considered
the possible development of malignancy. No mucosal changes suggestive of lymphoma were identified with
capsule endoscopy. Low attenuation mesenteric lymphadenopathy, without enlarged small bowel segments were
seen on computed tomography. CEUS revealed arterial rim enhancement around the necrotic mesenteric lymph
nodes, without venous wash-out. No malignant cells were identified on laparoscopic mesenteric lymph nodes
biopsies. The patient died due to fulminant liver failure 14 months later; the histopathological examination revealed
CD3/CD30-positive atypical T-cell lymphocytes in the liver, mesenteric tissue, spleen, gastric wall, kidney, lung and
bone marrow samples; no malignant cells were present in the small bowel samples.
Conclusions: CEUS findings in EATL complicating CMLNS include arterial rim enhancement of the mesenteric
tissue around the cavitating lymph nodes, without venous wash-out. This vascular pattern is not suggestive for
neoangiogenesis, as arteriovenous shunts from malignant tissues are responsible for rapid venous wash-out of the
contrast agent. CEUS failed to provide a diagnosis in this case.
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Figure 1 Duodenal biopsy: villous atrophy, crypt hyperplasia,
intraepithelial lymphocytes without atypical features.
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Cavitating mesenteric lymph node syndrome (CMLNS)
is a rare, poorly understood complication of celiac
disease characterized by central necrosis of mesenteric
lymph nodes [1]. Multiple areas of necrotizing cavitation
in reticulo-endothelial tissues are frequently associated
with splenic hypo-function, the presence of Howell-Jolly
bodies, monocytosis, lymphocytosis and increased
platelet count [1,2]. The estimated mortality rate is 50%
[1]. Enteropathy associated T cell lymphoma (EATL) is a
possible complication of the necrosis of mesenteric
lymph nodes [2,3]. Hepatic failure is a rare complication of
celiac disease of unknown pathogenesis; the predisposition
to autoimmunity may, in part, explain the involvement of
the liver [4]. In patients associating CMLNS, septicemia or
malignant T-lymphocyte infiltration of the liver may explain
the liver insufficiency [2,3].
Diagnosing the underlying condition of the cavitating
mesenteric lymph node syndrome (either infectious or
malignant) can be challenging; a lymphoma can still be
notoriously difficult to diagnose, despite multiple biopsies
[5]. Even lymphomas with T-cell immunophenotypic
features have been reported in extra intestinal sites
(liver, spleen), complicating celiac disease, but without
intestinal involvement [2].
Computed tomography (CT) or magnetic resonance
imaging (MRI) can detect fat-fluid levels in mesenteric
cystic masses, considered as specific findings for
CMLNS [6,7]; furthermore, these techniques can identify
a segmental enlargement of the small bowel, suggestive
for lymphoma. More recently developed, contrast
enhanced ultrasound (CEUS) can depict the blood flow
in small vessels, under 40 microns, useful to describe the
tumor angiogenesis patterning [8]. The intense, anarchic
arterial enhancement with rapid venous wash-out of the
contrast agent is highly suggestive for malignancy, since
the malignant tissue is characterized by numerous
arteriovenous shunts [8].
We report a case of celiac disease complicated with
CMLNS, with persisting symptoms despite adherence
to the gluten-free diet. The imaging and histological
examinations failed to document the presence of
malignancy during the patient’s lifetime. A fulminant
liver failure caused the patient’s death 14 months after
the initial diagnosis. The postmortem histopathological
examination revealed abnormal T-cell lymphocytes in
the liver, mesenteric tissue, spleen, gastric walls, kidney,
lungs and bone marrow; no malignant cells were present
in the examined small bowel samples.
Case presentation
A 51-year old male was investigated for chronic diarrhea,
episodes of moderate diffuse abdominal pain and 10-kg
weight loss. On physical examination, the patient presentedmuscle wasting, without any fever, hepatosplenomegaly or
jaundice. The stool studies were positive for steatorrhea.
The laboratory workup revealed moderate iron deficiency
anemia, signs of hyposplenism: Howell-Jolly bodies on
the peripheral blood smear, elevated platelet count,
hypocalcaemia and an elevated alkaline phosphatase
level. The serum endomysial and tissue transglutaminase
IgA antibodies were positive in high titre. Total villous
atrophy, crypt hyperplasia, increased intraepithelial
lymphocytes and increased plasma cells and lymphocytes
in the lamina propria were found on the duodenal biopsy
(Figure 1) performed by upper digestive endoscopy. The
intraepithelial lymphocytes were small, without atypical
features. The immunohistochemistry testing found intrae-
pithelial lymphocytes positive for CD3 (Figure 2) and few
lymphocytes positive for CD8 in lamina propria (Figure 3);
CD30 staining revealed isolated positive cells in lamina
propria (Figure 4). The abdominal ultrasound revealed
fluid-distended small bowel loops with an enlarged, hyper
echoic mesentery (Figure 5), anechoic cysts corresponding
to mesenteric lymph nodes and a reduced spleen size. We
established a diagnosis of celiac disease complicated with
CMLNS. A gluten-free diet was recommended and a
three-month monitoring schedule proposed.
Three months later, the patient complained of persistent
symptoms. The stool examination revealed a Yersinia
enterocolitica infection. The patient received adequate
antibiotic therapy, resulting in stool sterilization.
After six months of gluten-free diet, the clinical
manifestations were similar, despite diet adherence,
confirmed by the decline in tissue transglutaminase IgA
titre. An intestinal lymphoma was suspected and capsule
endoscopy performed, which investigated the entire
small bowel. This examination revealed an atrophic
villous pattern in the proximal jejunum, without mucosal
changes suggestive of lymphoma; a “bulging” mass with
Figure 2 Immunohistochemistry testing from initial duodenal
biopsy: intraepithelial lymphocytes positive for CD3.
Figure 4 Immunohistochemistry testing from initial duodenal
biopsy: negative CD30 staining.
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interpreted as compression from a mesenteric lymph
node. The entire small bowel was investigated by capsule
endoscopy. Mesenteric cystic masses with central low
attenuation and a thin enhancing rim were found on oral
and IV-contrast enhanced computed tomography (CT)
(Figure 7). No small bowel wall segmental enlargements
were present on CT enteroclysis. As the clinical suspicion
of malignancy was still high, a contrast-enhanced
ultrasound (CEUS) was considered in order to describe the
vascular pattern of the mesenteric tissue. After peripheral
venous injection of 4.8 ml of ultrasound contrast agent
(Sonovue), an arterial rim enhancement (Figure 8) was seen
around necrotic lymph nodes, without washout of the
contrast agent in the venous phase (Figure 9). Some of the
investigated masses had septa exhibiting the same
vascular pattern, suggesting an anarchic vascularization.
A diagnostic laparoscopy was performed with removalFigure 3 Immunohistochemistry testing from initial duodenal
biopsy: few lymphocytes positive for CD8 in lamina propria.of two lymph nodes. These cystic masses were found to
contain a milky fluid. The histopathological examination
of the samples revealed central homogeneous acidophilic
material, fibrotic walls with a rim of normal lymphocytes
at the periphery of necrotic lymph nodes and no signs
of malignancy or infection. The gluten-free diet and
monitoring was continued.
After another five months, the patient presented with
fever (39°Celsius) and severe liver failure. The blood
cultures were negative. The serological markers for viral
or autoimmune hepatitis and leptospirosis were also
negative. The already severe clinical status worsened,
with the development of hepatic encephalopathy and
severe upper gastrointestinal bleeding. Despite inten-
sive supportive treatment, the patient died 48 hours
after admission.Figure 5 Abdominal ultrasound – intestinal loops with
enlarged, hyperechoic mesentery.
Figure 6 Small bowel capsule endoscopy – “bulging mass”
without superficial erosions of the mucosa – (compressive necrotic
mesenteric lymph node).
Figure 8 Contrast-enhanced ultrasound - arterial phase
(27 seconds) – cystic mesenteric masses - arterial
rim enhancement.
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either fluctuant or firm, containing a milky fluid, were
found in the mesentery (Figure 10). The microscopic
examination of necrotic mesenteric lymph nodes
revealed a central homogeneous acidophilic material,
fibrotic walls and rare lymphocytes and plasmocytes in
the periphery (Figure 11). Infiltration of abnormal T-cell
lymphocytes, with atypical nuclear features, was present
in the surrounding adipose tissue (Figure 12). The
immunohistochemistry testing was positive for CD3
(Figure 13) and CD30. The same infiltrative tumor cells
were present in the liver, spleen, gastric walls, kidney,
lungs and bone marrow; no malignant cells were present
in the small bowel samples examined.Figure 7 Computed tomography – cystic mesenteric masses -
central low attenuation with enhanced rims (arrow).Discussion
The pathogenesis of CMLNS is not fully understood at
the moment. One of the proposed theories involved an
excessive antigenic exposure of the immune system via a
damaged intestinal mucosa, leading to depletion of
cellular lymphoid elements in the mesenteric lymph
nodes and spleen, causing a cystic change or ‘cavitation’
in some patients with celiac disease. An alternative
hypothesis is the necrosis of mesenteric lymph nodes
triggered by localized immune-mediated complement
activation and intravascular coagulation [7]. There were
several reports of lymph node necrosis associated with
intestinal infection with Mycobacterium spp, Yersinia
spp [1] or Tropheryma whippelii [9]. Our patient had anFigure 9 Contrast-enhanced ultrasound - venous phase
(35 seconds) – cystic mesenteric masses - no was/out of
contrast agent.
Figure 10 Necropsy gross findings - many nodular grayish-white
masses in the mesentery; a milky liquid was observed
after section.
Figure 12 Mesenteric adipose tissue - Hematoxylin-Eosine
staining, 20x: malignant lymphocytes.
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of his illness. However, this infection cannot be regarded
as the cause of CMLNS, because the symptoms persisted
even after adequate antibiotic treatment leading to stool
sterilization.
Half of the CMLNS patients have a poor prognosis,
but some reports mentioned a good outcome if a strict
gluten-free diet was observed [10,11]. In celiac disease,
however, a malignant lymphoma may also be the cause
of mesenteric lymph node necrosis, being in part
responsible for the poor prognosis [1].
The diagnosed of CMLNS is based on imaging and
typical histopathological examination. The necrotizing
mesenteric lymph nodes are described as anechoic cysts
on an abdominal ultrasound. Computed tomographyFigure 11 Histological examination (Hematoxylin-Eosine
staining, 20x) mesenteric pseudo-cyst – central homogeneous
acidophilic material, fibrotic walls, rare lymphocytes and
plasmocytes in the periphery (arrows).studies reveal central low attenuation with enhancing
rims [6]. Sometimes fat-fluid levels within the masses
may be apparent on CT [6]; this feature is considered
unique to the cavitated mesenteric adenopathies
associated with celiac disease. The specific fat-fluid
levels were also found in one CMLNS case on an
MRI examination [7].
The diagnosis of complicated cavitating mesenteric
lymph node syndrome (either infectious or malignant)
can be challenging; a lymphoma is still notoriously
difficult to diagnose, despite multiple biopsies [5].
Lymphomas with T-cell immunophenotypic features
have been reported in extra intestinal sites (liver, spleen),
as a complication of celiac disease, but without intestinal
involvement [2]. In our case, the initial biopsies did not
reveal abnormal T-cell lymphocytes, but the virtual lack
of immunopositivity for CD8 intraepitelial lymphocytes
might have been suggestive of a diagnosis of refractoryFigure 13 Mesenteric adipose tissue - Immunohistochemistry
testing: mesenteric adipose tissue positive for CD3 (40x).
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large CD30+ lymphocytes in the lamina propria in early
biopsies could have represented minimal infiltration by
the patient’s lymphoma [13].
The capsule endoscopy and CT did not find any small
bowel mucosal changes suggestive of enteral lymphoma
and no other small bowel biopsies were taken. The
contrast-enhanced ultrasound was performed in order to
obtain more specific information about the vascular
pattern of the lymph node “walls” and the surrounding
mesenteric tissue.
The assessment of neovascularization by CEUS is
based on its ability to depict the blood flow in small vessels.
In malignant tumors a rapid and intense enhancement is
seen in the arterial phase, with rapid wash-out of the
contrast agent in the venous phase. This vascular pattern
is explained by arteriovenous shunts. The timing of hypo
enhancing on CEUS may be correlated with tumor cell
differentiation; well-differentiated tumors wash out
more slowly than poorly differentiated ones [14]. The
quantitative CEUS parameters in assessing neoangiogenesis
processes were documented on hepatocarcinoma, ovarian
and breast malignant tumors [15-17]. In malignant lymph
nodes, CEUS depicts vessels penetrating the node’s capsule
away from the hilum; reactive adenopathies have a singular
vascular pedicle at the hilum with regular branches
towards the periphery. Based on these findings, CEUS
can improve the results of Doppler ultrasound in the
differential diagnosis of lymph nodes with a sensitivity,
specificity and accuracy rate of up to 84%, 79% and 80%
respectively [18]. These studies were performed on
superficial lymph nodes. However, in several studies,
lymphomas seem to have a benign vascular pattern
[19,20]. To date there is not enough evidence for the
accuracy of CEUS in assessing different types of lymphoma
[21]. In our case, intense enhancement was observed in
the arterial phase in the surrounding mesenteric tissue
of necrotic lymph nodes, without rapid vascular
washout in the venous phase, but it was not suggestive
of malignancy. CEUS failed to provide a diagnosis of
tumor neoangiogenesis in this case. This lack of venous
wash-out may be due to arborizing venules found in
some peripheral T-cell lymphomas [22].
In this case, 18 F-FDG PET scan could have detected
early EATL; previous studies documented its role in
patients with refractory celiac disease, being more sensitive
than CT in detecting sites affected by lymphoma [23]. This
investigation was not available in our institution.
In patients associating CMLNS, liver failure may be due
to septicemia or to malignant T-lymphocyte infiltration of
the liver [2,3]. In our case, the microscopic examination
revealed abnormal T-cell lymphocytes in the liver, spleen,
mesenteric tissue, gastric walls, kidney, lung and bone
marrow. No malignant cells were observed in the smallbowel samples examined. It is possible that the EATL was
unsampled, despite multiple biopsies, as it was previous
reported [5]. Other authors described the same features of
a rare peripheral T-cell lymphoma, associated with celiac
disease, characterized by a rearrangement of the gamma-
delta T-cell receptor, responsible for the aggressiveness of
this tumor [2,24]. T-cell receptor PCR or flow cytometry
were not performed in our case.
Conclusions
This is the first report of a CEUS examination in
CMLNS complicated with EATL that revealed an arterial
rim enhancement around necrotic lymph nodes without
venous wash-out. As this vascular pattern is not suggestive
for tumor neoangiogenesis, the investigation failed to
provide a diagnosis on this case.
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